Project Grant HT94252510740
Award Date
8/1/25
Completion Date
7/31/27
Dollars Obligated
$210K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
University City, MO 63130, USA
Similar Awards
This federal Project Grant award of $256,208 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a research project titled "DEUTERIUM METABOLIC IMAGING TO NONINVASIVELY MEASURE METABOLIC REPROGRAMMING IN GLIOBLASTOMA" at The Washington University in University City, Missouri. The project aims to develop and apply advanced metabolic imaging techniques using deuterium to non-invasively measure metabolic changes in glioblastoma, an...
This Federal Project Grant award for $236,777.00 was provided by the Defense Health Agency to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). The funding supports RAPID HIGH RESOLUTION METABOLIC IMAGING FOR IMPROVED MANAGEMENT OF PATIENTS WITH GLIOMA, a research project aimed at developing advanced imaging techniques to better manage patients with glioma, a type of brain cancer. The award term runs...
This Project Grant award for $901,906 from the Defense Health Agency supports research to develop "AUTOMATIC RAPID, HIGH RESOLUTION METABOLIC IMAGING FOR IMPROVED MANAGEMENT OF PATIENTS WITH GLIOMA". The funding is provided through the Military Medical Research and Development program (CFDA 12.420) which focuses on biomedical research to address military and veteran health needs. The research, conducted by the Regents of the University of California, San Francisco (UCSF), aims to...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The federal Project Grant award of $161,000.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by Duke University to investigate breast cancer brain metastases. The research aims to integrate immunogenomic and phenotypic vulnerabilities to improve outcomes for this challenging condition. The award period runs from April 1, 2025 to March 31, 2026. This grant is part of the Defense Health Agency's strategic...
This federal Project Grant award of $155,500.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by The Washington University in University City, Missouri. The award, effective from September 30, 2025 to September 29, 2027, will investigate the "Pathophysiologic Effects of Obesogenic Diet in Neurofibromatosis Type 1 and Impact on Tumor Formation." This research aims to transform healthcare for military service members,...
The U.S. Defense Health Agency awarded a $234,000 Project Grant to the Medical College of Wisconsin, Inc. (MCW) under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "WHOLE-BRAIN RADIOPATHOMIC MAPPING OF GLIOBLASTOMA INFILTRATION", will fund advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The research, conducted from August 1, 2025 to July 31, 2027, aims to develop innovative...
The Defense Health Agency awarded a $159,892 Project Grant to the University of Illinois under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into "Metabolic Vulnerabilities Associated to G12C Inhibitor Resistance" from January 1, 2022 through December 31, 2023. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will...
The Department of Defense's Defense Health Agency awarded a $700,032 Project Grant to Duke University under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective August 1, 2025 through July 31, 2029, will fund research to investigate "Imaging Strategies and Biomarkers for Detecting the Metabolic Interplay of Glutamine and Aspartate in RCC." This research aims to transform healthcare for military service members, veterans, and the broader public by...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,594,419.00 to The Regents of the University of California, San Francisco (UCSF) to conduct radiopathomic mapping of tumor burden for personalized management of IDH-mutant glioma. The award period runs from September 1, 2025 to August 31, 2028. As a leading academic medical center and research institution, UCSF will leverage its expertise in translational...